Keywords: |
treatment outcome; cancer surgery; clinical feature; clinical trial; histopathology; review; cancer localization; doxorubicin; cancer combination chemotherapy; cancer risk; gemcitabine; cancer adjuvant therapy; cancer radiotherapy; methotrexate; cancer staging; magnetic resonance imaging; neoplasm staging; cancer grading; dacarbazine; metastasis; tomography, x-ray computed; cytogenetics; vincristine; diagnostic approach route; tumor biopsy; age factors; ifosfamide; carcinogenesis; sarcoma; head and neck cancer; head and neck neoplasms; cancer size; dactinomycin; soft tissue sarcoma; cancer registry; molecular biology; mesna; sex factors; granulocyte colony stimulating factor; tomography, emission-computed; humans; prognosis; human; priority journal
|